Deeponcology.ai vs TrialJectory
Deeponcology.ai vs TrialJectory, compared side by side on 15 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Deeponcology.ai is on 24/100 and TrialJectory on 58/100.
Where each one leads
Deeponcology.ai
- agent readiness: 50/100 against 32/100
TrialJectory
- our overall score: 58/100 against 24/100
- domain rating: 39/100 against 0/100
- headcount: 17 against 2
- LinkedIn following: 4,387 against 474
At a glance
| Measure | Deeponcology.ai | TrialJectory |
|---|---|---|
| What it is | Integrating oncology, AI, and computer vision for clinically significant medical imaging applications in cancer diagnosis and treatment. | AI-powered platform connecting cancer patients to advanced treatments and clinical trials. |
| Category | Healthcare, Medical Imaging, Cancer, HealthTech | Healthcare, Clinical Trials, Cancer, HealthTech |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | Software |
| Founded | 2018 | 2017 |
| Headquarters | Not published | New York, United States |
| Status | Inactive | Active |
Size, funding and growth
| Measure | Deeponcology.ai | TrialJectory |
|---|---|---|
| Employees | 2 | 17 |
| Headcount growthLast 12 months | Not published | -33.1% |
| Total funding | Not published | $39.7M |
| Latest round | Bootstrapped | Series A |
| LinkedIn followers | 474 | 4,387 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Deeponcology.ai | TrialJectory |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 24/100 | 58/100 |
| Traction | 5/100 | 51/100 |
| Team | 30/100 | 70/100 |
| Search visibility | 28/100 | 36/100 |
| Quality | Not published | 62/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (50/100) | F (32/100) |
| Domain ratingLink authority, 0-100 | 0/100 | 39/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Deeponcology.ai | TrialJectory |
|---|---|---|
| Hosting | Not detected | AWS |
| CDN | Not detected | CloudFront |
| Frameworks | Not detected | Next.js |
Deeponcology.ai vs TrialJectory: common questions
Which is better, Deeponcology.ai or TrialJectory?
On our 0-100 score TrialJectory rates higher (58/100 against 24/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 15 data points above: read the rows that match what you are buying for.
How do Deeponcology.ai and TrialJectory compare on the numbers?
Deeponcology.ai leads on agent readiness (50/100 against 32/100). TrialJectory leads on our overall score (58/100 against 24/100), domain rating (39/100 against 0/100), headcount (17 against 2), LinkedIn following (4,387 against 474).
Read the full Deeponcology.ai review and pricing or the TrialJectory review and pricing. You can also browse other Deeponcology.ai alternatives we track.